Quick Takeaways
- Yap Kim Choy filed SCHEDULE 13G/A for Cyclacel Pharmaceuticals, Inc. Common Stock, par value $0.001 per share (CYCC).
- Disclosed ownership: 21%.
- Date of event: 01 Sep 2025.
Yap Kim Choy - 01 Sep 2025 SCHEDULE 13G/A Report for Cyclacel Pharmaceuticals, Inc. Common Stock, par value $0.001 per share (CYCC)
- Filing Manager
- Yap Kim Choy
- Reporting Manager
- Yap Kim Choy
- Symbol
- CYCC
- Shares outstanding
- 4,200,385 shares
- Disclosed Ownership
- 872,000 shares
- Ownership
- 21%
- Form type
- SCHEDULE 13G/A
- Filing time
- 02 Sep 2025, 06:09:58 UTC
- Date of event
- 01 Sep 2025
- Previous filing
- 18 Aug 2025
- Next filing
- 31 Oct 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Yap Kim Choy disclosed 21% ownership in Cyclacel Pharmaceuticals, Inc. Common Stock, par value $0.001 per share (CYCC) on 01 Sep 2025."
What Changed
- Previous schedule filing date: 18 Aug 2025.
- Current filing was accepted on 02 Sep 2025, 06:09.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Yap Kim Choy | 21% | 872,000 | 872,000 | 0 | /s/ Yap Kim Choy | Yap Kim Choy |